Abstract Details

Title Intravenous Synthetic Peptide MBP8298 Significantly Delayed Disease Progression in an HLA Class II-Defined Cohort of Patients with Progressive Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ingrid Catz, PhD	No disclosure on file
	No disclosure on file
Kenneth G. Warren, MD (The University of Alberta)	No disclosure on file
Prachi Pawar, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
David Walk, MD, FAAN (Dept. of Neurology)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��